The 5th BIOHK2026 Hong Kong International Biotechnology Forum & Exhibition was held at the Hong Kong Convention and Exhibition Centre from September 9 to 12. Haikou National High-Tech Zone organized a delegation of high-quality enterprises from the park to participate in the exhibition. As a key biomanufacturing enterprise within the zone, Hainan Huayan Collagen Technology Co., Ltd. showcased its innovative achievements in bioactive peptides originating from the Hainan Free Trade Port to global business visitors.

This year’s congress brought together nearly 200 exhibitors and over 500 distinguished international speakers, featuring more than 50 parallel sub-forums covering over 40 countries and regions worldwide, and is expected to attract more than 10,000 professional industry attendees. Forum topics covered cutting-edge areas including AI in life sciences, cell and gene therapy, synthetic biology, innovative pharmaceuticals, modern traditional Chinese medicine, longevity and anti-aging. Complemented by exclusive closed-door meetings, gala dinner on cruise ships and other featured activities, the event serves as an integrated communication platform connecting academia, industry, capital and regulatory authorities. Leveraging its geographic advantage linking mainland China and the rest of the world, Hong Kong acts as a vital gateway for biotech enterprises from mainland China to access the international market.

Taking the opportunity for international exchange at BIOHK2026, Hainan Huayan presented brochures of bioactive peptide raw materials and application solutions. Powered by self-developed patented enzymatic hydrolysis technology, Huayan’s products enable the extraction and preparation of active peptide fragments. These ingredients can be applied in multiple sectors such as functional nutritional foods, health consumer goods and skincare raw materials, and are exported to many countries and regions across the globe. At the exhibition booth, Huayan’s team held in-depth exchanges with biotech partners from Hong Kong, Macao, Southeast Asia, Europe, America and beyond. Discussions focused on custom raw material development, joint technical R&D and the building of international supply chains to explore cross-border industrial cooperation opportunities.

“Rooted in Hainan, Serving the Globe.” With 22 years of dedicated work in small-molecule peptides, Hainan Huayan is a high-tech enterprise with full-chain R&D and industrialization capabilities in China’s peptide industry. The company has participated in the formulation of national and industrial standards related to collagen peptides, holds more than 120 authorized patents, and has built a complete industrial system covering raw materials and formula application development, continuously strengthening its technological prowess in biomanufacturing.

Participation in BIOHK2026 marks an important milestone in Hainan Huayan’s global expansion strategy. Nurtured by the favorable development environment of the Hainan Free Trade Port, Hainan Huayan will continue to increase investment in biomanufacturing technological innovation and refine high-quality peptide products. Fully utilizing Hong Kong’s role as a science and innovation hub, Huayan will keep connecting with resources from global industrial and innovation chains, expand the international influence of “Hainan Intelligent Manufacturing”, and join hands with worldwide partners to unlock new prospects for the big health industry.